Oruka Therapeutics (ORKA) Misses Q4 EPS by 45c

Oruka Therapeutics (NASDAQ: ORKA) reported Q4 EPS of ($0.45). Revenue for the quarter came in at $0.

For earnings history and earnings-related data on Oruka Therapeutics (ORKA) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Faraday Future reveals robot lineup and new products at Automate
• Isoplus selects Navan to manage global travel and expense program